Myezom 2mg Injection

Price 2203 INR/ Thousand

Get a Price/Quote

MOQ : 5 Vials

Myezom 2mg Injection Specification

Pacakaging (Quantity Per Box)
1 Vial

Origin of Medicine
India

Indication
Treatment of multiple myeloma and mantle cell lymphoma

Dosage Form
Lyophilized Powder for Injection

Salt Composition
Bortezomib 2mg

Drug Type
Allopathic

Ingredients
Bortezomib

Physical Form
Injection

Function
Antineoplastic (Anti-cancer) agent

Recommended For
Multiple Myeloma, Mantle Cell Lymphoma

Dosage
As directed by physician

Dosage Guidelines
Administered intravenously or subcutaneously as per doctors instructions

Suitable For
Adults

Quantity
2 mg per vial

Storage Instructions
Store below 25C, protect from light

ATC Code
L01XX32

Prescription Requirement
Prescription Only Medicine

Reconstitution
Reconstitute as per instructions with normal saline

Warning
For hospital use only. Not to be self-administered.

Molecular Formula
C19H25BN4O4

Administration Route
Intravenous or Subcutaneous

Shelf Life
24 months from manufacturing date

Container Type
Glass Vial

Appearance
White to off-white lyophilized powder

Myezom 2mg Injection About

Myezom 2mg Injection is used in the treatment of multiple myeloma and mantle-cell lymphoma. It shows its working by stopping or slowing down the growth of cancer cells.Myezom 2mg Injection is given as an injection by a qualified medical professional. Your doctor will decide what dose is necessary and how often you need to take it. This will depend on what you are being treated for and may change from time to time. You should take it exactly as your doctor has advised. Taking it in the wrong way or taking too much can cause very serious side effects. It may take several weeks or months for you to see or feel the benefits but do not stop taking it unless your doctor tells you to.Fatigue, nausea, vomiting, and loss of appetite are some common side effects of this medicine. You may be advised to drink plenty of fluids every day during the treatment. You should not drive or operate machinery as medicine may cause tiredness and dizziness. This medicine may reduce the number of blood cells (decrease red blood and white blood cells) in your blood, thereby, increasing the susceptibility to infections. Regular blood tests are required to check your blood cells along with heart, liver, and blood uric acid levels.Before taking Myezom 2mg Injection, consult with your doctor if you have any liver, kidney, heart disease or bleeding problem. It is important to consult a doctor if you develop symptoms like memory loss or trouble in thinking. Many other medicines can affect, or be affected by, this medicine so let your healthcare team know all medications you are using. This medicine is not recommended during pregnancy or while breastfeeding. The use of effective contraception by both males and females during treatment is important to avoid pregnancy.

Advanced Treatment for Hematologic Cancers

Myezom 2mg Injection offers a proven treatment option for adults with multiple myeloma and mantle cell lymphoma. Its active ingredient, Bortezomib, interferes with cancer cell survival, providing significant clinical benefits. The formulation is delivered as a lyophilized powder, ensuring stable and precise dosing when reconstituted by healthcare professionals.

Safe Administration-Hospital Use Only

To ensure optimal safety and efficacy, Myezom is indicated strictly for hospital use and must not be self-administered. Administration routes include intravenous or subcutaneous injection, determined by the healthcare provider according to specific patient needs.

Quality Assurance and Storage

Each glass vial is produced under stringent conditions in India, ensuring pharmaceutical quality. For best results, store Myezom below 25C, away from light, and adhere to the shelf life of 24 months from the manufacturing date. Proper handling preserves its potency during cancer therapy.

FAQ's of Myezom 2mg Injection:

Q: How is Myezom 2mg Injection administered to patients?

A: Myezom 2mg Injection is administered either intravenously or subcutaneously by a healthcare professional in a hospital setting. Self-administration is strictly prohibited due to safety considerations.

Q: What conditions is Myezom 2mg Injection used to treat?

A: This medication is recommended for the treatment of multiple myeloma and mantle cell lymphoma in adult patients, as directed by a physician.

Q: When should Myezom be administered, and how often?

A: Myezom should be given according to the dosage and schedule prescribed by the treating physician, which may vary based on the patient's condition and response to therapy.

Q: Where should Myezom 2mg Injection be stored before use?

A: Store the vial below 25C in a place protected from light. Ensure it is used before its expiry, which is 24 months from the manufacturing date.

Q: What is the process for preparing Myezom 2mg Injection for administration?

A: The lyophilized powder must be reconstituted using normal saline following the manufacturer's instructions, and only healthcare professionals should handle the reconstitution and administration procedure.

Q: What are the benefits of using Myezom 2mg Injection in cancer therapy?

A: Myezom contains Bortezomib, an antineoplastic agent that inhibits cancer cell growth, contributing to improved control and outcomes for those diagnosed with multiple myeloma or mantle cell lymphoma.

Q: Can Myezom 2mg Injection be supplied or purchased without a prescription?

A: No, Myezom is classified as a prescription-only medicine and must be supplied, distributed, or traded by authorized professionals, strictly for hospital administration.

Tell us about your requirement